Point State Capital LP Neurocrine Biosciences Inc Transaction History

Point State Capital LP

  • $5.69 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019
SELL
$72.24 - $91.27 $476,783 - $602,382
-6,600 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$69.31 - $91.53 $457,446 - $604,098
6,600 New
6,600 $581,000
Q3 2018

Nov 14, 2018
SELL
$98.88 - $125.85 $6.42 Million - $8.17 Million
-64,900 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$75.3 - $105.99 $4.89 Million - $6.88 Million
64,900 New
64,900 $6.38 Million

Others Institutions Holding NBIX

# of Institutions
628
Shares Held
94.4M
Call Options Held
505K
Put Options Held
343K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.3B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Point State Capital LP Portfolio

Follow Point State Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Point State Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email